$Evofem Bioscienc you won't have to wait until end of the year. Buyout due diligence already in progress. M&A DD work takes about 4 weeks on average (in my experience), by end of June rumors will "leak", followed by an official announcement. Most likely Bayer and Merck race to finish line - it already is a competitive market so nobody will want to lose market share. Besides, whoever acquires Evofem will take away from competitors market share. In the upcoming 2 or 3 weeks, this will climb up. Watch for insider activity also. At a minimum, 1 to 1.5B market evaluation IF an offer is made in the next month, which would mean 25 to 35 dollars a share. This is how it works with First of its kind products - big pharma can't take the risk of this becoming a big product which could eat away at their market share...Neither one of the big boys like Bayer, Merck, Teva will talk about it, but believe me they are already looking into it...soon something will leak, trust me... 10 to 12 bucks by mid June, 18 bucks by end of June...25 to 30 dollar buyout...early to mid July..